Katherine Stueland

Chief Executive Officer at GENEDX HOLDINGS CORP.

Net worth: 5 M $ as of 31/05/2026

50 year

77 connections

Health Services

Health Technology

Consumer Services

Profile

Currently, Katherine A. Stueland is Chief Executive Officer & Director at GeneDx Holdings Corp.
starting in 2026, President & Chief Executive Officer at GeneDx LLC since 2021, Director at Cancan Health, and President & Director at Sema4 OpCo, Inc. Formerly, Ms. Stueland was President & Chief Executive Officer at GeneDx, Inc., Director at Rivkin Center for Ovarian Cancer, VP-Corporate Communications & Investor Relations at Dendreon Corp.
from 2011 to 2012, Principal at Vivo Communications, LLC in 2013, and Chief Commercial Officer at Invitae Corp.
from 2016 to 2021.
Education includes an undergraduate degree from Miami University, conferred in 1997.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
GENEDX HOLDINGS CORP. CLASS A 0.36%	16/06/2026	104,372 ( 0.36% )	5 M $	31/05/2026

Katherine Stueland active positions

Companies	Position	Start
GENEDX HOLDINGS CORP.	Chief Executive Officer	29/04/2022
Cancan Health	Director/Board Member	-
GeneDx LLC GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services	Chief Executive Officer	01/06/2021
Mount Sinai Genomics, Inc. Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases	President	-

All active positions of Katherine Stueland

Former positions of Katherine Stueland

Companies	Position	End
INVITAE CORPORATION	Investor Relations Contact	01/10/2016
Vivo Communications, LLC Vivo Communications, LLC Specialty TelecommunicationsCommunications Provides telecommunication services	Corporate Officer/Principal	01/12/2013
DENDREON CORPORATION	Investor Relations Contact	01/06/2012
GeneDx, Inc. GeneDx, Inc. Medical/Nursing ServicesHealth Services Performs genetic testing for rare hereditary disorders	Chief Executive Officer	-
Rivkin Center for Ovarian Cancer Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Provides funds for ovarian cancer researchers	Director/Board Member	-

See the detail of Katherine Stueland's experience

Training of Katherine Stueland

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Katherine Stueland's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Dendreon Corp. Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer	Health Technology
Invitae Corp. Invitae Corp. Medical/Nursing ServicesHealth Services Provides genetic testing services for patients	Health Services
Miami University Miami University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
GeneDx, Inc. GeneDx, Inc. Medical/Nursing ServicesHealth Services Performs genetic testing for rare hereditary disorders	Health Services
Rivkin Center for Ovarian Cancer Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Provides funds for ovarian cancer researchers	Commercial Services
Cancan Health
Vivo Communications, LLC Vivo Communications, LLC Specialty TelecommunicationsCommunications Provides telecommunication services	Communications
Mount Sinai Genomics, Inc. Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases	Health Services
GeneDx Holdings Corp. GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services	Health Services
GeneDx LLC GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services	Health Services